FDA’s 2024 draft guidance signals broader expectations for data monitoring committee (DMC) independence, communication, documentation, and sponsor decision-making. For sponsors and contract research organizations (CROs), now is
In the complex landscape of clinical trials, the data monitoring committee (DMC) serves as the cornerstone at the intersection of
In an era where clinical trials are increasingly global, it’s more imperative than ever to leverage international expertise. Data and
DMC services Data monitoring committee (DMC) Independent DMC oversight supported by a 1500+ expert member network Advarra DMC services provide
Achieving diversity, equity, and inclusion (DEI) in clinical trials is crucial for producing comprehensive and effective medical research benefitting all
In the realm of pharmaceutical development, ensuring the safety and efficacy of new treatments is paramount. One crucial aspect of
The FDA’s 2024 draft guidance emphasizes the critical role of independent DMCs in clinical trials, enhancing oversight, safety, and trial integrity.
Ensure your DSMB meets regulatory standards. Learn best practices in administration, member selection, and overcoming challenges in clinical trial oversight.
Explore the state of DE&I in clinical research with survey insights on diversity plans, budgeting efforts, and progress in trial representation.
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
DMCs play a vital role in clinical trials by independently reviewing interim data for safety and effectiveness, ensuring participant protection throughout the study.
The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight
